Methods for producing aflibercept in chemically defined media having reduced aflibercept variants | Patent Number 11535663

US 11535663 B2
Application Number17383322
Publication NumberUS 20220033471 A1
Pendency1 year, 5 months, 8 days
Filled DateJul 22, 2021
Priority DateDec 6, 2019
Publication DateFeb 3, 2022
Expiration DateDec 5, 2039
Inventor/ApplicantsAmy Johnson
Meghan Casey
Shunhai Wang
Shawn Lawrence
Jaimie Mastrogiacomo
Ning Li
ExaminesRAMIREZ, DELIA M
Art Unit1652
Technology Center1600
Assignments
Regeneron Pharmaceuticals
Current
Regeneron Pharmaceuticals
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.